Clinical applicability of microarray technology in the diagnosis, prognostic stratification, treatment and clinical surveillance of cervical adenocarcinoma
- PMID: 23016775
Clinical applicability of microarray technology in the diagnosis, prognostic stratification, treatment and clinical surveillance of cervical adenocarcinoma
Abstract
Invasive cervical cancer is a common problem worldwide and while rates of squamous cell carcinoma of the cervix (SCC) have been declining with the implementation of community screening programs, adenocarcinoma of the cervix (ADC) has not shown a similar response to screening. At this time, the two entities are tested for and treated with the same clinical algorithms, namely gynecologic cytology and molecular testing for HPV DNA. However, ADC arises more proximally within the cervical canal and frequently occurs below the superficial mucosal lining, precluding it from being easily diagnosed with cytologic examination. Furthermore, ADC has a more aggressive course than SCC and is significantly less responsive to radiotherapy. These factors combine to produce a lesion that is diagnosed at a higher stage and has an overall poorer prognosis than SCC. While both lesions have pathogenic origins with the high-risk species of Human papilloma viruses (HPV), the high association of ADC with HPV 18, a virus with a higher genome integration rate, suggests that the transformation pathway of ADC differs from SCC. Modern methods of molecular analysis can produce gene expression profiles of various cell types and preliminary studies have shown that SCC and ADC do, indeed, produce a distinct genetic signature and can be reproducibly segregated. This technology has promise for clinical applicability in the diagnosis, the prognostic stratification, formation of a treatment care plan and post-therapeutic monitoring of ADC.
Similar articles
-
Cervical adenocarcinoma: moving towards better prevention.Vaccine. 2011 Nov 15;29(49):9148-58. doi: 10.1016/j.vaccine.2011.09.115. Epub 2011 Oct 6. Vaccine. 2011. PMID: 21983356 Review.
-
Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.Acta Oncol. 2011 Nov;50(8):1215-9. doi: 10.3109/0284186X.2011.584556. Epub 2011 Jul 5. Acta Oncol. 2011. PMID: 21726177
-
Differential cyclooxygenase-2 expression in squamous cell carcinoma and adenocarcinoma of the uterine cervix.Int J Radiat Oncol Biol Phys. 2004 Nov 1;60(3):822-9. doi: 10.1016/j.ijrobp.2004.04.030. Int J Radiat Oncol Biol Phys. 2004. PMID: 15465199
-
[Study on the clinicopathologic features of 88 cases with mucinous cervical adenocarcinoma].Zhonghua Fu Chan Ke Za Zhi. 2013 Aug;48(8):602-6. Zhonghua Fu Chan Ke Za Zhi. 2013. PMID: 24199926 Chinese.
-
Adenocarcinoma of the cervix: should we treat it differently?Curr Oncol Rep. 2015 Apr;17(4):17. doi: 10.1007/s11912-015-0440-6. Curr Oncol Rep. 2015. PMID: 25708801 Review.
Cited by
-
Multi-omic analysis reveals HIP-55-dependent regulation of cytokines release.Biosci Rep. 2020 Mar 27;40(3):BSR20200298. doi: 10.1042/BSR20200298. Biosci Rep. 2020. PMID: 32134471 Free PMC article.
-
Human basonuclin 2 up-regulates a cascade set of interferon-stimulated genes with anti-cancerous properties in a lung cancer model.Cancer Cell Int. 2017 Feb 6;17:18. doi: 10.1186/s12935-017-0394-x. eCollection 2017. Cancer Cell Int. 2017. PMID: 28184177 Free PMC article.
-
Investigating Cell Signaling with Gene Expression Datasets.CourseSource. 2019;6:10.24918/cs.2019.1. doi: 10.24918/cs.2019.1. Epub 2019 Jan 3. CourseSource. 2019. PMID: 32855998 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials